HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsuneo Saga Selected Research

HOP-8P

3/2002Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsuneo Saga Research Topics

Disease

105Neoplasms (Cancer)
03/2022 - 02/2002
14Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 02/2002
10Mesothelioma
05/2019 - 09/2007
9Neoplasm Metastasis (Metastasis)
04/2017 - 06/2003
7Carcinoma (Carcinomatosis)
02/2021 - 04/2004
7Hypoxia (Hypoxemia)
01/2021 - 02/2012
7Lung Neoplasms (Lung Cancer)
12/2018 - 12/2004
5Malignant Mesothelioma
05/2019 - 09/2007
4Colonic Neoplasms (Colon Cancer)
04/2016 - 09/2012
4Carcinogenesis
03/2015 - 09/2007
3Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2013
3Glioblastoma (Glioblastoma Multiforme)
12/2019 - 06/2015
3Hepatocellular Carcinoma (Hepatoma)
12/2012 - 09/2006
3Inflammation (Inflammations)
10/2012 - 05/2002
2Lymphoma (Lymphomas)
03/2022 - 11/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 09/2014
2Esophageal Neoplasms (Esophageal Cancer)
03/2020 - 06/2006
2Body Weight (Weight, Body)
10/2018 - 09/2018
2Hyperthyroidism
01/2018 - 02/2004
2Glioma (Gliomas)
01/2017 - 01/2013
2Leukemia
04/2016 - 12/2015
2Breast Neoplasms (Breast Cancer)
02/2016 - 10/2015
2Mitochondrial Diseases (Mitochondrial Disease)
12/2015 - 02/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015 - 06/2011
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2015 - 01/2013
2Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 01/2007
2Necrosis
09/2014 - 08/2004
2Parkinson Disease (Parkinson's Disease)
11/2013 - 02/2012

Drug/Important Bio-Agent (IBA)

12Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 - 03/2003
12IntegrinsIBA
11/2017 - 05/2011
10Glucose (Dextrose)FDA LinkGeneric
03/2020 - 02/2002
10Contrast MediaIBA
01/2018 - 02/2002
8Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2010
8Monoclonal AntibodiesIBA
09/2018 - 02/2010
8Pharmaceutical PreparationsIBA
10/2017 - 04/2010
7Peptides (Polypeptides)IBA
04/2017 - 07/2007
7Radioisotopes (Radionuclides)IBA
06/2016 - 09/2003
6AcidsIBA
12/2018 - 04/2011
6ManganeseIBA
01/2016 - 03/2002
6nitroxylIBA
12/2015 - 10/2011
5cyclic arginine-glycine-aspartic acid peptideIBA
04/2017 - 01/2013
4AntigensIBA
03/2022 - 02/2002
4Therapeutic UsesIBA
11/2017 - 09/2003
4PolymersIBA
01/2017 - 01/2013
4Immunoglobulin G (IgG)IBA
01/2017 - 05/2010
4RadiopharmaceuticalsIBA
10/2015 - 02/2004
4AntibodiesIBA
01/2015 - 04/2005
4AsbestosIBA
02/2012 - 09/2007
3Acetates (Acetic Acid Esters)FDA Link
12/2019 - 01/2013
3Thromboplastin (Tissue Factor)IBA
04/2019 - 01/2017
3Amino Acid Transport Systems (Amino Acid Transporter)IBA
12/2018 - 05/2015
3isobutyric acidIBA
12/2018 - 10/2012
3Transferrin Receptors (Transferrin Receptor)IBA
03/2017 - 01/2015
3MicellesIBA
01/2017 - 01/2013
3Liposomes (Liposome)IBA
01/2017 - 01/2015
3Indicators and Reagents (Reagents)IBA
04/2016 - 02/2012
3CopperIBA
09/2015 - 01/2008
3copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
09/2015 - 02/2012
3Methionine (L-Methionine)FDA Link
06/2013 - 12/2004
3ApoferritinsIBA
06/2013 - 09/2007
3Small Interfering RNA (siRNA)IBA
01/2013 - 04/2010
3ErbB Receptors (EGF Receptor)IBA
07/2012 - 08/2010
3Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2011 - 04/2005
3Superoxide DismutaseIBA
05/2011 - 01/2008
3HexokinaseIBA
04/2007 - 02/2002
3Fluorine-18IBA
09/2006 - 06/2003
2Pentetic Acid (DTPA)FDA LinkGeneric
03/2022 - 01/2013
2Indium-111IBA
03/2022 - 09/2003
2fluoroazomycin arabinosideIBA
08/2020 - 11/2015
2Amino AcidsFDA Link
12/2018 - 08/2013
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2018 - 10/2011
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2015
2Yttrium-90IBA
11/2017 - 06/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 05/2011
2FibrinIBA
09/2017 - 01/2013
2arginyl-glycyl-aspartic acidIBA
04/2017 - 01/2016
2CarbonIBA
01/2017 - 06/2013
2Biological ProductsIBA
01/2017 - 02/2012
2EverolimusFDA Link
04/2016 - 12/2015
22- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
04/2016 - 12/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2016 - 12/2015
2Red Fluorescent ProteinIBA
04/2016 - 11/2008
2LuciferasesIBA
02/2016 - 12/2014
2SolutionsIBA
01/2016 - 01/2013
2TEMPOIBA
12/2015 - 11/2013
2Superoxides (Superoxide)IBA
12/2015 - 11/2013
2Trastuzumab (Herceptin)FDA Link
10/2015 - 02/2002
2Diacetyl (Biacetyl)IBA
09/2015 - 02/2012
2ferric oxide (iron oxide)IBA
06/2015 - 08/2013
2protoporphyrin IXIBA
10/2014 - 08/2013
2Ethylene Glycol (Monoethylene Glycol)IBA
08/2013 - 01/2013

Therapy/Procedure

34Therapeutics
03/2022 - 02/2004
12Radiotherapy
03/2022 - 09/2003
8Precision Medicine
10/2017 - 01/2014
7Radioimmunotherapy
05/2019 - 01/2013
6Aftercare (After-Treatment)
01/2021 - 05/2011
4Drug Therapy (Chemotherapy)
01/2017 - 07/2006
4Heavy Ion Radiotherapy
01/2013 - 11/2008
3Lasers (Laser)
02/2016 - 01/2013
2Transplantation
03/2015 - 01/2011